Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
News
05/07/2024
Evi Arthur
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for...
05/07/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
05/07/2024
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig...
05/07/2024
Psych Congress Network
Geriatric Patient with son in long term care setting
News
05/07/2024
Jolynn Tumolo
Patients with tardive dyskinesia (TD) in long-term care settings have a high comorbidity and polypharmacy burden, with half taking medications that may worsen TD, according to a poster presentation at the APA annual meeting.
Patients with tardive dyskinesia (TD) in long-term care settings have a high comorbidity and polypharmacy burden, with half taking medications that may worsen TD, according to a poster presentation at the APA annual meeting.
Patients with tardive dyskinesia...
05/07/2024
Psych Congress Network
woman looking down on phone
News
05/07/2024
Jolynn Tumolo
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major...
05/07/2024
Psych Congress Network
Edward Kaftarian, MD.
Videos
05/03/2024

Featuring Edward Kaftarian, MD

Featuring Edward Kaftarian, MD ...
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian,...
05/03/2024
Psych Congress Network
brain imaging
News
05/02/2024
Meagan Thistle
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant...
05/02/2024
Psych Congress Network
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
News
05/01/2024
Evi Arthur
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of...
05/01/2024
Psych Congress Network
FDA approval stamp
News
04/30/2024
Meagan Thistle
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network
Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
News
04/29/2024
Jolynn Tumolo
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease...
04/29/2024
Neurology
Desiree Matthews, PHMNP-BC
Videos
04/29/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...
Join Desiree Matthews, PMHNP-BC, as she explores the limitations of traditional antipsychotic agents and off-label therapies in bipolar disorder treatment.
Join Desiree Matthews, PMHNP-BC, as she explores the limitations of traditional antipsychotic agents and off-label therapies in bipolar disorder treatment.
Join Desiree Matthews, PMHNP-BC,...
04/29/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement